TopFunds

Bristol-Myers Squibb Company

NYSE: BMY

Stock price

63.06 USD

(+2.85%) 5 years

Drug Manufacturers - General

Insider Transactions

5Y price score: 3
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: +2.85%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
09-sep.-26Sale(6,249)64.6(403,498)18,748Massacesi Cristianofficer: EVP,Chief Med Offr,Head of Devlink
25-aug.-26Sale(500)67.5(33,750)16,862Holzer Phil Mofficer: SVP and Controllerlink
30-jun.-26Award607--44,986YALE PHYLLIS Rdirectorlink
30-jun.-26Award889--70,361Samuels Theodore R. IIdirectorlink
30-jun.-26Award673--41,069Rice Derica Wdirectorlink
30-jun.-26Award607--16,333McMullen Michael R.directorlink
30-jun.-26Award607--72,816Arduini Peter Jdirectorlink
01-apr.-26Sale(25,519)61.6(1,571,970)163,729Elkins David Vofficer: EVP, Chief Financial Officerlink
01-apr.-26Sale(4,481)62.1(278,046)159,248Elkins David Vofficer: EVP, Chief Financial Officerlink
31-mar.-26Award577--43,904YALE PHYLLIS Rdirectorlink

42.5

52-week range

68.6

63.06

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

8.9 %

Dividend Yield TTM

4 %

Market cap $

$ 128,813

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

13.9

Price / Book TTM

5.8

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.1

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

43.7 %

20.5 %

47.6 %

Free cash flow per share growth

(13.6) %

6.9 %

722.3 %

Earnings per share growth

153.1 %

186.7 %

255.7 %

Dividends

Previous dividend:0.63 per share, Paid, Ex-div date Jul 02, 2026
Next dividend:0.63 per share, Declared, Ex-div date Oct 02, 2026

Analyst ratings

Price Target Low

59

Price Target High

82

Price Target Median

70

Buy

20

Hold

20

Sell

2

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
1
2.7
0.6
3
2
(4)
3.1
3
3.9
(4.4)
3.5
13.5%
2.2
2.4
2.6
2.9
3.1
3.1
02FCF per share
0.8
1.1
2.6
3.7
4.3
5.9
6.8
5.6
6.1
6.9
6.3
23.5%
6.5
7.1
7.8
8.6
9.4
9.5
03Dividends per share
Help
Adjusted for splitsLearn more
1.5
1.1
1.6
1.6
1.6
2.3
1.5
2.2
2.3
2.4
2.5
5.2%
-
-
-
-
-
-
04Dividends payout, %
158.3%
57.2%
255.9%
53.1%
77.9%
(45.3)%
62.9%
73.2%
59.1%
(54.4)%
71.5%
(7.6)%
-
-
-
-
-
-
05Revenue
$ 16,560
$ 19,427
$ 20,776
$ 22,561
$ 26,145
$ 42,518
$ 46,385
$ 46,159
$ 45,006
$ 48,300
$ 48,195
11.3%
$ 53,629
$ 59,675
$ 66,403
$ 73,889
$ 82,219
$ 84,686
06ㅤ% Change
-
17.3%
6.9%
8.6%
15.9%
62.6%
9.1%
(0.5)%
(2.5)%
7.3%
(0.2)%
11.3%
11.3%
11.3%
11.3%
11.3%
11.3%
11.3%
07Net Income
1,565
4,457
1,007
4,920
3,439
(8,995)
6,994
6,327
8,025
(8,948)
7,054
16.3%
4,572
5,087
5,661
6,299
7,009
7,219
08ㅤ% Margin
9.5%
22.9%
4.9%
21.8%
13.2%
(21.2)%
15.1%
13.7%
17.8%
(18.5)%
14.6%
8.5% A
8.5%
8.5%
8.5%
8.5%
8.5%
8.5%
09CFO
2,105
3,058
5,275
7,066
8,210
14,052
16,207
13,066
13,860
15,190
14,156
21%
14,844
16,518
18,380
20,452
22,758
23,441
10ㅤ% Of revenue
12.7%
15.7%
25.4%
31.3%
31.4%
33.1%
34.9%
28.3%
30.8%
31.5%
29.4%
27.7% A
27.7%
27.7%
27.7%
27.7%
27.7%
27.7%
11CAPEX
(820)
(1,215)
(1,055)
(951)
(836)
(753)
(973)
(1,118)
(1,209)
(1,248)
(1,311)
4.8%
(1,374)
(1,440)
(1,509)
(1,582)
(1,658)
(1,737)
12ㅤ% Change
-
48.2%
(13.2)%
(9.9)%
(12.1)%
(9.9)%
29.2%
14.9%
8.1%
3.2%
5.1%
4.8% A
4.8%
4.8%
4.8%
4.8%
4.8%
4.8%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
1,285
1,843
4,220
6,115
7,374
13,299
15,234
11,948
12,651
13,942
12,845
25.9%
13,470
15,078
16,871
18,871
21,100
21,704
14Total assets
31,748
33,707
33,551
34,986
129,944
118,481
109,314
96,820
95,159
92,603
90,038
11%
99,930
110,909
123,095
136,619
151,628
168,287
15ㅤ% Change
-
6.2%
(0.5)%
4.3%
271.4%
(8.8)%
(7.7)%
(11.4)%
(1.7)%
(2.7)%
(2.8)%
11%
11%
11%
11%
11%
11%
11%
16Total liabilities
17,324
17,360
21,704
20,859
78,246
80,599
73,308
65,702
65,674
76,215
71,532
15.2%
79,391
88,114
97,794
108,539
120,463
133,698
17ㅤ% Of assets
54.6%
51.5%
64.7%
59.6%
60.2%
68%
67.1%
67.9%
69%
82.3%
79.5%
79.5% A
79.5%
79.5%
79.5%
79.5%
79.5%
79.5%
18Shareholders Equity
14,424
16,347
11,847
14,127
51,698
37,882
36,006
31,118
29,485
16,388
18,506
2.5%
20,539
22,796
25,300
28,080
31,165
34,589
19Net Debt
4,304
2,471
2,541
438
35,192
37,127
31,617
31,594
30,000
40,854
36,930
24%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
1,679,000
1,680,000
1,652,000
1,637,000
1,712,000
2,258,000
2,245,000
2,146,000
2,078,000
2,027,000
2,041,000
2%
2,081,240
2,122,274
2,164,117
2,206,785
2,250,294
2,294,660
21ㅤ% Change
-
0.1%
(1.7)%
(0.9)%
4.6%
31.9%
(0.6)%
(4.4)%
(3.2)%
(2.5)%
0.7%
2%
2%
2%
2%
2%
2%
2%
22ROA
4.9%
13.2%
3%
14.1%
2.7%
(7.6)%
6.4%
6.5%
8.4%
(9.7)%
7.8%
-
4.6%
4.6%
4.6%
4.6%
4.6%
4.3%
23ROE
10.9%
27.3%
8.5%
34.8%
6.7%
(23.7)%
19.4%
20.3%
27.2%
(54.6)%
38.1%
-
22.3%
22.3%
22.4%
22.4%
22.5%
20.9%
24Interest coverage
21.4
31
26.7
34.9
9.8
3.2
7.2
7.5
7.3
5
7.3
-
-
-
-
-
-
-
25Dividend Yield
2.2%
2.6%
2.6%
3.1%
2.5%
2.9%
3.2%
3%
4.5%
4.2%
4.6%
-
-
-
-
-
-
-
26P/E Ratio
70.9
21.9
100.5
17.2
31.8
(15.6)
19.8
24.2
13.2
(12.8)
15.6
-
-
-
-
-
-
-
27Stock price range
57-71
49-77
47-65
49-69
43-64
46-67
54-69
61-81
48-75
40-60
43-63
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
114,673
97,653
100,806
84,883
109,444
140,064
138,479
153,254
106,160
114,647
110,092
(0.4)%
218,992
244,581
272,729
303,691
337,750
-
29FCF Yield
1.1%
1.9%
4.2%
7.2%
6.7%
9.5%
11%
7.8%
11.9%
12.2%
11.7%
26.4%
6.2%
6.2%
6.2%
6.2%
6.3%
-
30Average stock price
64
63
56.1
58.9
53.5
56.9
61.5
71.3
61.5
49.8
52.9
(1.9)%
105.2
115.2
126
137.6
150.1
-
31 CEO
CB
Christopher Boerner